Company Description

TrAMPoline Pharma is a cellular immunotherapy company that is developing personalized (autologous) therapies for solid tumor cancers. Their lead therapeutic candidate, MightyTIL™ is a gene engineered tumor infiltrating lymphocyte (TIL) targeting orphan cancer indications (sarcoma, head and neck cancer) and melanoma. MightyTIL has demonstrated significantly enhanced anti-tumor activity in multiple animal tumor models as compared with conventional unmodified TIL.